Abstract
Oral squamous cell carcinoma (OSCC) is the most common subtype of head and neck cancer, with late diagnosis in advanced stages, often metastasizing to cervical lymph nodes, and with a high rate of disease recurrence. Despite advances in therapy and increased knowledge about risk factors associated with OSCC, the survival rate for patients has not improved substantially in the last few yea…